J.W. Cole Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

J.W. Cole Advisors, Inc.

$2.33 Billion
Q3 2024

A detailed history of J.W. Cole Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 802 shares of REGN stock, worth $658,442. This represents 0.04% of its overall portfolio holdings.

Number of Shares

802

Previous 719 11.54%

Holding current value

$658,442

Previous $755,000 11.66%

% of portfolio

0.04%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$1024.09 - $1201.76 $84,999 - $99,746	83 Added 11.54%	802 $843,000
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $31,795 - $38,562	-36 Reduced 4.77%	719 $755,000
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $27,983 - $30,793	-31 Reduced 3.94%	755 $726,000
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $4,651 - $5,290	6 Added 0.77%	786 $690,000
Q3 2023 Oct 24, 2023	SELL	$692.45 - $844.37 $69,937 - $85,281	-101 Reduced 11.46%	780 $641,000
Q2 2023 Jul 27, 2023	SELL	$700.03 - $830.35 $43,401 - $51,481	-62 Reduced 6.57%	881 $633,000
Q1 2023 May 03, 2023	BUY	$680.49 - $826.97 $161,276 - $195,991	237 Added 33.57%	943 $774,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $9,176 - $9,963	-13 Reduced 1.81%	706 $509,000
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $34,438 - $43,459	-60 Reduced 7.7%	719 $495,000
Q2 2022 Jul 27, 2022	SELL	$548.35 - $738.84 $34,546 - $46,546	-63 Reduced 7.48%	779 $460,000
Q1 2022 Jun 10, 2022	SELL	$595.12 - $698.43 $330 Million - $387 Million	-554,449 Reduced 99.85%	842 $588,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $330 Million - $387 Million	554,437 Added 64922.37%	555,291 $34,000
Q4 2021 Jan 25, 2022	SELL	$543.48 - $670.97 $21,195 - $26,167	-39 Reduced 4.37%	854 $539,000
Q3 2021 Oct 26, 2021	SELL	$574.03 - $680.96 $1,148 - $1,361	-2 Reduced 0.22%	893 $540,000
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $216,069 - $255,252	457 Added 104.34%	895 $500,000
Q1 2021 Apr 28, 2021	SELL	$446.73 - $548.2 $43,779 - $53,723	-98 Reduced 18.28%	438 $207,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $22,001 - $27,967	46 Added 9.39%	536 $259,000
Q3 2020 Nov 05, 2020	BUY	$544.75 - $658.21 $266,927 - $322,522	490 New	490 $274,000

Others Institutions Holding REGN

# of Institutions

1,505

Shares Held

85.3M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account

J.W. Cole Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History